Cargando…
Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
BACKGROUND: Even though the post-operative outcome varies greatly among patients with nodal positive colon cancer (UICC stage III), personalized prediction of systemic disease recurrence is currently insufficient. We investigated in a retrospective setting whether genetic and immunological biomarker...
Autores principales: | Sperlich, Andreas, Balmert, Alexander, Doll, Dietrich, Bauer, Sabine, Franke, Fabian, Keller, Gisela, Wilhelm, Dirk, Mur, Anna, Respondek, Michael, Friess, Helmut, Nitsche, Ulrich, Janssen, Klaus-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194664/ https://www.ncbi.nlm.nih.gov/pubmed/30340556 http://dx.doi.org/10.1186/s12885-018-4940-2 |
Ejemplares similares
-
Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
por: Nitsche, Ulrich, et al.
Publicado: (2016) -
Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference
por: Barz, Christoph, et al.
Publicado: (2021) -
Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
por: Kistner, Larissa, et al.
Publicado: (2017) -
Outcome after surgery for acute right-sided colonic ischemia without feasible vascular intervention: a single center experience of 58 patients over 6 years
por: Käser, Samuel A, et al.
Publicado: (2015) -
The evidence based dilemma of intraperitoneal drainage for pancreatic resection – a systematic review and meta-analysis
por: Nitsche, Ulrich, et al.
Publicado: (2014)